(Q34134516)

31 July 2017

title

Analysis of the structural basis of specificity of inhibition of the Abl kinase by STI571. (English)

1 reference

31 July 2017

Brian J Druker

4

0 references

author name string

Amie S Corbin

series ordinal

1

1 reference

31 July 2017

Elisabeth Buchdunger

series ordinal

2

1 reference

31 July 2017

Furet Pascal

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

20 June 2002

1 reference

Journal of Biological Chemistry

31 July 2017

published in

1 reference

31 July 2017

volume

277

1 reference

31 July 2017

issue

35

1 reference

31 July 2017

page(s)

32214-32219

1 reference

Chronic myelogenous leukemia: biology and therapy

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

21 January 2018

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Acute leukaemia in bcr/abl transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Roots of clinical resistance to STI-571 cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111525200

21 January 2018

Identifiers

DOI

10.1074/JBC.M111525200

1 reference

release_kcixtp2775clrjv6gk5u5zvanq

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kcixtp2775clrjv6gk5u5zvanq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference